Cancer patient talking with a doctor

NHS England set to roll out new breast cancer treatment

Thousands of breast cancer patients could see the amount of time they spend in hospital cut down dramatically as NHS England begins to roll out a new injection treatment across the country.

The new combined treatment, called PHESGO, is injected and takes a little as five minutes to prepare and administer, compared to previous treatments which saw patients receive two infusions which could take up to two and a half hours.

More than 3,600 new patients a year will benefit from the treatment, as well as others who will switch from their current treatment to the new single injection.

The PHESGO treatment is being rolled out after the NHS struck a deal with the treatment’s manufacturer.

As part of its rollout, the five-minute injection will be offered to eligible patients with HER2-positive breast cancer, which accounts for 15% of all breast cancers.

It can be given alongside chemotherapy or on its own.

By reducing the amount of time patients are spending in hospital, the new five-minute injected treatment also significantly cuts the Covid-19 infection risk for patients, as well as freeing up time for clinicians in chemotherapy units.

The NHS England announcement formed the latest in a series of cancer care innovations introduced during the pandemic, including Covid-secure surgery hubs and a £160m investment in ‘Covid-friendly’ cancer drugs, as part of efforts to minimise the growing backlogs to cancer treatment due to the past 12 months.

NHS National Clinical Director for Cancer, Professor Peter Johnson, said: “The NHS has continued to adopt new treatments rapidly throughout the pandemic, to improve cancer care for patients. This new injection, which can substantially cut treatment time for people with breast cancer, is the latest in a series of changes which have meant the NHS has been able to deliver vital cancer treatment while keeping patients safe from Covid.

“I am delighted that this is now available to people having breast cancer treatment, limiting the time they need to spend in hospital and giving the NHS another way to continue treating as many cancer patients as possible, as we have done throughout the pandemic.”

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, added: “Approval of PHESGO being used on the NHS in England is fantastic news as thousands of women with HER2 positive breast cancer will now benefit from a quicker and kinder treatment method.

“Reducing the time patients need to spend in hospital, this more efficient treatment method also promises to free up precious time for healthcare professionals when the NHS is already under unprecedented strain due to Covid-19.

“Today’s announcement reflects the latest of continued advances in breast cancer treatment, and now we hope to see Roche and NHS decision-makers working together to ensure PHESGO is rapidly made available across all of the UK so that even more patients and healthcare professionals alike can reap its benefits.”

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all